The 3 analysts offering 12-month price forecasts for Harrow Health Inc have a median target of 16.50, with a high estimate of 17.00 and a low estimate of 16.00. The median estimate represents a +90.97% increase from the last price of 8.64.
The current consensus among 3 polled investment analysts is to Buy stock in Harrow Health Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.01
Reporting Date Nov 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.